$ONC Q2 '26 Earnings Results & Recap
BeOne Medicines Ltd. raised its 2026 total revenue guidance to $6.6 billion to $6.8 billion, with GAAP operating income of $1.0 billion to $1.1 billion and non-GAAP operating income of $1.7 billion to $1.8 billion.